ArticleJournal of robotic surgery2022
Colorectal cancer surgery: by Cambridge Medical Robotics Versius Surgical Robot System-a single-institution study. Our experience.
Article in Journal of robotic surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 4 syntheses or guidelines pooled it, 30 citations in OpenAlex.
- Safety and feasibility of the versius robotic surgical system for colorectal resection: proportional meta-analysis of single-arm studies.Journal of robotic surgery · 2026Pooled it
- Applicability and results of the versius surgical robotic system in colorectal surgery: a systematic review of the literature.Journal of robotic surgery · 2025Pooled it
- Emerging multi-port soft tissue robotic systems: a systematic review of clinical outcomes.Journal of robotic surgery · 2024Pooled it
- New Robotic Platforms in General Surgery: What's the Current Clinical Scenario?Medicina (Kaunas, Lithuania) · 2023Pooled it
- Da VinciSurgical endoscopy · 2026Observational
- Robotic adrenalectomy: comparison of DaVinci, HUGO™-RAS and VersiusUpdates in surgery · 2026Article
- Article
- Total Mesorectal Excision with New Robotic Platforms: A Scoping Review.Journal of clinical medicine · 2024Article
- Comparative analysis of the short and medium-term efficacy of the Da Vinci robotWorld journal of gastrointestinal surgery · 2024Article
- Stereo Visual Servoing Control of a Soft Endoscope for Upper Gastrointestinal Endoscopic Submucosal Dissection.Micromachines · 2024Article
- Review of robotic surgery platforms and end effectors.Journal of robotic surgery · 2024Review
- Clinical implementation of the Versius robotic surgical system in visceral surgery-A single centre experience and review of the first 175 patients.Surgical endoscopy · 2023Article
- Treatment of an unusual case of Meckel's diverticulum with a new robotic platform.International journal of surgery case reports · 2022Article
- Assessment of the Versius Robotic Surgical System in Minimal Access Surgery: A Systematic Review.Journal of clinical medicine · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the previous experiences in performing laparoscopic for over a period of 15 years and da Vinci colorectal surgeries from 2010 to 2013, we started operating using the Cambridge Medical Robotics (CMR) Versius Surgical Robot System. The aim of the study is a prospective analysis and evaluation of short-term results of consecutive patients to study the technical feasibility and oncological outcome of robot-assisted low anterior resection (LAR) and ultralow anterior resection (ULAR), using the CMR Versius Surgical Robot System. This study was conducted at single minimal access surgery institute. 31 patients with colorectal adenocarcinoma underwent robot-assisted LAR and ULAR between August 2019 and March 2020. Patient characteristics, perioperative parameters and complications were evaluated. Surgical and pathological outcomes such as quality of Total Mesorectal Excision (TME), free circumferential resection margins and number of lymph nodes dissected were also evaluated. Of 31 patients, 23 were men and 8 women, with mean age of 55.6 years. The mean robotic operative time was 51 min and the mean blood loss was 55 ml. The mean robot docking and undocking time was 17 min and 5 min, respectively. The mean hospital stay was 7 days. The longitudinal and circumferential resection margins were negative in all patients. Histopathological reports of 27 among 31 patients showed complete TME. Splenic flexure of colon mobilization was done laparoscopically. We feel that Versius robot has the qualities in terms of dexterity, vision and intuitive movements, and to translate this technical ability into oncological safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.